Dr. Kang is director of Translational Research at the Fresco Institute of Parkinson’s and Movement Disorders, and co-director of Parekh Center for Interdisciplinary Neurology at NYU Grossman School of Medicine. He was previously chief of Movement Disorders Division at Columbia University, founded by Dr. Stanley Fahn. Dr. Kang received his medical degree from Johns Hopkins University and completed his neurology residency and movement disorders fellowship training at Columbia University.
Dr. Kang is interested in biomarker development in Parkinson’s disease and related disorders such as multiple system atrophy. He led the Fox Investigation for New Discovery of Biomarkers (BioFIND) and serves on biospecimen review committees for MJFF PPMI and NIH PDBP. Dr. Kang also studies the molecular and cellular mechanisms of brain circuit plasticity underlying both beneficial and detrimental effects of dopaminergic therapy such as dyskinesia using rodent models with cell type-specific modulation and recording, correlated with behaviors.
Associated Grants
-
-
-
-
Gene Expression Changes in Striatal Cholinergic Interneurons Associated with Levodopa-induced Dyskinesia
2014